Chevron Corporation (NYSE:CVX) will be recognized this evening by
the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria
(GBC) for its longstanding commitment to fight the spread of HIV/AIDS,
tuberculosis and malaria around the world. Chevron will receive the
GBC’s prestigious Richard C. Holbrooke Award for Business Leadership in
recognition of the company’s global public health programs.
The award recognizes Chevron’s leadership in delivering customized
workplace and community-based health education, awareness-building,
prevention and treatment programs across the company’s worldwide
operations. Chevron’s global public health programs continue to grow
through the development of strategic partnerships and sustainable
programs in communities around the world.
“These awards are given to an elite group of companies who set the
standard for excellence in business action to defeat disease,” said GBC
President and CEO John Tedstrom. “They show what a business can do, and
how to do it exceedingly effectively. We need more businesses to take
this kind of action. The fight against HIV/AIDS, tuberculosis and
malaria cannot be won without the corporate sector stepping up and
playing an active role — and Chevron is doing exactly the kind of thing
that all companies can and should do. Chevron doesn’t just talk, they
take action. And their action saves lives.”
“Chevron believes that helping to eradicate HIV/AIDS, tuberculosis and
malaria is a clear example of how long-term business interests and
commitment to corporate responsibility are intrinsically linked,” said
Dr. Richard Wilkins, Chevron’s general manager of Health and Medical
Services. “With more than 62,000 employees and business operations
around the world — including some of the most severely affected
by these health crises — responding to these epidemics is a
vitally important responsibility for our company.”
Chevron has been a leader in the fight for global health. In 2008, the
company became the first Corporate Champion of The Global Fund to Fights
AIDS, Tuberculosis and Malaria — committing $30 million over three years
to Global Fund activities to help control and eradicate these diseases
in Angola, Nigeria, South Africa, Indonesia, Thailand and the
Philippines. Chevron also partnered with Vestergaard Frandsen to
manufacture special anti-malaria-treated curtains for windows and doors
for the company’s entire Angolan workforce.
